Nivolumab for relapsed/refractory classical Hodgkin lymphoma after autologous transplant: Full results after extended follow-up of the multicohort multicenter phase 2 CheckMate 205 trial Meeting Abstract

   


Authors: Engert, A.; Fanale, M.; Santoro, A.; Armand, P.; Ansell, S.; Zinzani, P. L.; Timmerman, J.; Collins, G.; Ramchandren, R.; Cohen, J.; De Boer, J. P.; Kuruvilla, J.; Savage, K.; Trneny, M.; Rodig, S.; Shipp, M.; Kato, K.; Sumbul, A.; Farsaci, B.; Younes, A.
Abstract Title: Nivolumab for relapsed/refractory classical Hodgkin lymphoma after autologous transplant: Full results after extended follow-up of the multicohort multicenter phase 2 CheckMate 205 trial
Meeting Title: 22nd Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 102
Issue: Suppl. 2
Meeting Dates: 2017 Jun 22-25
Meeting Location: Madrid, Spain
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2017-06-26
Start Page: 145
Language: English
ACCESSION: WOS:000404127001306
PROVIDER: wos
PMCID: PMC5492673
Notes: Meeting Abstract: S142 -- Source: Wos